2 new investors on the share capital increase in a proportion of 49 percent on Pace Project One Co., Ltd and 48.7 percent on Pace Project Three Co., Ltd. The Company remeasured the remaining
Total Expenses 4,334.0 65.1 4,697.1 69.2 363.1 8.4 Profit before share of loss from investments in joint ventures, finance cost and income tax expenses 2,323.2 34.9 2,092.7 30.8 (230.6) (9.9) Share of
% Administrative Expenses (42.8) (37.5) 14.3% (118.6) (82.4) 44.0% Finance Costs (84.4) (84.2) 0.3% (245.5) (282.7) -13.2% Share of Profit from Investments in Associates and Joint Ventures 418.5 547.3 -23.5% 1,510.4
580.1 562.9 3.1% Other Income4 145.7 162.7 -10.5% Administrative Expenses (197.5) (130.8) 51.0% Finance Costs (342.0) (366.6) -6.7% Share of Profit from Investments in Associates and Joint Ventures
27.46 38.56 (11.10) (28.79) Net Profit (Loss) (41.80) (83.80) 42.00 50.12 Earnings per share (Baht per share) (0.0092) (0.0185) 0.0093 50.27 Net Profit The company and subsidiaries realized net loss of
Expenses 27.46 38.55 (11.09) (28.77) Net Profit (Loss) (41.80) (83.80) 42.00 50.12 Earnings per share (Baht per share) (0.0092) (0.0185) 0.0093 50.27 Net Profit The company and subsidiaries realized net loss
continuously increased patients treated by replacement therapy with dialysis machines steadily until full capacity. While in the year 2016 only one clinic had been operated (dialysis service was firstly operated
scheduled flights, net interline revenues from flights operated by other airlines and marketed by it on a code-share basis, revenues derived from non-codeshare interline sales by it of seats on other airlines
consisted of the Chaloem Ratchamongkhon Project ( Hua Lamphong Station - Bang Sue Station) , currently operated and the MRT Blue Line Extension Project (Hua Lamphong Station - Lak Song Station and Bang Sue